SCHEMBL1423595

SCHEMBL1423595

Ic1cccc(-c2ccncc2)c1-c1ccc(OCc2ccccc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F2 P00734 2/20 0.50
GSTP1 P09211 2/20 0.49
KCNH2 Q12809 1/20 0.48
GRIN2B Q13224 1/20 0.48
PRMT5 O14744 1/20 0.46
SMN1; SMN2 Q16637 3/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
MEN1 O00255 1/20 0.44
POLB P06746 1/20 0.44
KMT2A Q03164 1/20 0.44
IKBKE Q14164 1/20 0.43
MAOB P27338 3/20 0.42
LMNA P02545 1/20 0.42
CYP1A2 P05177 1/20 0.42
PTGS1 P23219 1/20 0.42
SLC6A2 P23975 1/20 0.42
CYP2C19 P33261 1/20 0.42
PTGS2 P35354 1/20 0.42
SLC6A3 Q01959 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1423718 0.85 IKBKE (0.49) F2GSTP1KCNH2GRIN2BPRMT5
SCHEMBL1423506 0.82 MGAM (0.53) F2GSTP1PRMT5IKBKELMNA
SCHEMBL1957932 0.80 F2 (0.62) F2GSTP1KCNH2GRIN2BPRMT5
SCHEMBL1423767 0.80 GHSR (0.48) F2GSTP1KCNH2GRIN2BPRMT5
SCHEMBL1423716 0.80 MEN1 (0.58) F2GSTP1KCNH2GRIN2BPRMT5
SCHEMBL1423766 0.75 MGAM (0.52) GSTP1PRMT5IKBKEMAOBLMNA
SCHEMBL1758642 0.74 F2 (0.52) F2GSTP1KCNH2GRIN2BPRMT5
SCHEMBL29978578 0.74 GSTP1 (0.71) GSTP1SMN1; SMN2NPC1RAB9AMEN1
SCHEMBL953509 0.73 F2 (0.65) F2KCNH2GRIN2BSMN1; SMN2NPC1
SCHEMBL1772434 0.73 IKBKB (0.50) F2GSTP1PRMT5MAOBIKBKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110224204-A1 DI-SUBSTITUTED PHENYL COMPOUNDS ENVIVO PHARMACEUTICALS, INC. 2011-09-15 US disclosed
EP-2297131-A2 DI-SUBSTITUTED PHENYL COMPOUNDS AS PHOSPHODIESTERASE 10 INHIBITORS Envivo Pharmaceuticals, Inc. (US) 2011-03-23 EP disclosed
WO-2009158467-A2 DI-SUBSTITUTED PHENYL COMPOUNDS ENVIVO PHARMACEUTICALS, INC. (US) 2009-12-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110224204-A1 DI-SUBSTITUTED PHENYL COMPOUNDS PDE10A, PDE1A, PDE12 F2 3486/4885GSTP1 270/4885KCNH2 2799/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.